AI assistant
BIOGEN INC. — Director's Dealing 2010
Mar 23, 2010
30291_dirs_2010-03-23_f421f903-49c3-4bb2-850f-2beb0ed10054.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIOGEN IDEC INC. (BIIB)
CIK: 0000875045
Period of Report: 2010-03-19
Reporting Person: MULLEN JAMES C (Director, CEO & President)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2010-03-19 | Common Stock | M | 287500 | $51.85 | Acquired | 418649 | Direct |
| 2010-03-19 | Common Stock | M | 46721 | $49.03 | Acquired | 465370 | Direct |
| 2010-03-19 | Common Stock | S | 334221 | $59.9721 | Disposed | 131149 | Direct |
| 2010-03-22 | Common Stock | M | 106279 | $49.03 | Acquired | 237428 | Direct |
| 2010-03-22 | Common Stock | S | 106279 | $59.9528 | Disposed | 131149 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2010-03-19 | Non-qualified Stock Option (Right to Buy) | $51.85 | M | 287500 | Disposed | 2010-06-16 | Common Stock (287500) | Direct |
| 2010-03-19 | Non-qualified Stock Option (Right to Buy) | $49.03 | M | 46721 | Disposed | 2011-12-14 | Common Stock (46721) | Direct |
| 2010-03-22 | Non-qualified Stock Option (Right to Buy) | $49.03 | M | 106279 | Disposed | 2011-12-14 | Common Stock (106279) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 75000 | Indirect |
Footnotes
F1: Exercise/sale pursuant to a trading plan intended to comply with Rule 10b5-1 of the Securities Exchange Act of 1934.
F2: Full information regarding the number of shares sold at each separate price will be provided upon request by the SEC staff, the issuer, or a security holder of the issuer.
F3: This represents the weighted average price for shares sold at a range between $59.95 (low) and $60.15 (high).
F4: This represents the weighted average price for shares sold at a range between $59.95 (low) and $59.98 (high).
F5: The stock option became exercisable in seven (7) equal annual installments, commencing one year after the grant date of 06/16/00.
F6: The stock option became exercisable in four (4) equal annual installments, commencing one year after the grant date of 12/14/01.
F7: Granted under one of the Issuer's stock option plans, in an exempt transaction under SEC rule 16(b)-3(d).